nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—PTGS2—amyotrophic lateral sclerosis	0.542	1	CbGaD
Antipyrine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.27	1	CbGbCtD
Antipyrine—TRPA1—cranial nerve—amyotrophic lateral sclerosis	0.035	0.296	CbGeAlD
Antipyrine—TRPA1—peripheral nervous system—amyotrophic lateral sclerosis	0.023	0.195	CbGeAlD
Antipyrine—TRPA1—nerve—amyotrophic lateral sclerosis	0.0179	0.152	CbGeAlD
Antipyrine—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00552	0.573	CrCbGaD
Antipyrine—TRPA1—spinal cord—amyotrophic lateral sclerosis	0.00478	0.0406	CbGeAlD
Antipyrine—Methylphenobarbital—GRIA2—amyotrophic lateral sclerosis	0.00411	0.427	CrCbGaD
Antipyrine—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.0041	0.0348	CbGeAlD
Antipyrine—TRPA1—nervous system—amyotrophic lateral sclerosis	0.00403	0.0342	CbGeAlD
Antipyrine—TRPA1—central nervous system—amyotrophic lateral sclerosis	0.00388	0.0329	CbGeAlD
Antipyrine—PTGS2—appendage—amyotrophic lateral sclerosis	0.00352	0.0299	CbGeAlD
Antipyrine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00161	0.0136	CbGeAlD
Antipyrine—SLC22A6—brain—amyotrophic lateral sclerosis	0.00126	0.0107	CbGeAlD
Antipyrine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.00121	0.0103	CbGeAlD
Antipyrine—PTGS2—embryo—amyotrophic lateral sclerosis	0.00117	0.00991	CbGeAlD
Antipyrine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000986	0.00836	CbGeAlD
Antipyrine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000921	0.00781	CbGeAlD
Antipyrine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000811	0.00688	CbGeAlD
Antipyrine—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000747	0.00633	CbGeAlD
Antipyrine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000723	0.00613	CbGeAlD
Antipyrine—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000697	0.00591	CbGeAlD
Antipyrine—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000666	0.00565	CbGeAlD
Antipyrine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000649	0.00551	CbGeAlD
Antipyrine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000625	0.0053	CbGeAlD
Antipyrine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000609	0.00517	CbGeAlD
Antipyrine—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000587	0.00498	CbGeAlD
Antipyrine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000587	0.00498	CbGeAlD
Antipyrine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000574	0.00486	CbGeAlD
Antipyrine—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000565	0.00479	CbGeAlD
Antipyrine—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000561	0.00476	CbGeAlD
Antipyrine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000553	0.00469	CbGeAlD
Antipyrine—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.00054	0.00458	CbGeAlD
Antipyrine—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000528	0.00448	CbGeAlD
Antipyrine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000496	0.00421	CbGeAlD
Antipyrine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00049	0.00416	CbGeAlD
Antipyrine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000483	0.00409	CbGeAlD
Antipyrine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000472	0.004	CbGeAlD
Antipyrine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000466	0.00395	CbGeAlD
Antipyrine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000465	0.00394	CbGeAlD
Antipyrine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000454	0.00385	CbGeAlD
Antipyrine—PTGS1—brain—amyotrophic lateral sclerosis	0.000449	0.00381	CbGeAlD
Antipyrine—PTGS2—brain—amyotrophic lateral sclerosis	0.000429	0.00364	CbGeAlD
Antipyrine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000369	0.00313	CbGeAlD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000124	0.00204	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000123	0.00202	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000122	0.00201	CbGpPWpGaD
Antipyrine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000122	0.00199	CbGpPWpGaD
Antipyrine—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000121	0.00199	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00012	0.00197	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00012	0.00196	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000115	0.00189	CbGpPWpGaD
Antipyrine—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000115	0.00188	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000114	0.00188	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000114	0.00187	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000113	0.00185	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00011	0.0018	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00011	0.0018	CbGpPWpGaD
Antipyrine—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000109	0.00178	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000108	0.00176	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000107	0.00176	CbGpPWpGaD
Antipyrine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000106	0.00174	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—DAO—amyotrophic lateral sclerosis	0.000104	0.00171	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000102	0.00167	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000102	0.00167	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000102	0.00167	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000101	0.00165	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0001	0.00164	CbGpPWpGaD
Antipyrine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	9.72e-05	0.00159	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.6e-05	0.00157	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	9.38e-05	0.00154	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.36e-05	0.00153	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.31e-05	0.00153	CbGpPWpGaD
Antipyrine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	9.3e-05	0.00152	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.28e-05	0.00152	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.28e-05	0.00152	CbGpPWpGaD
Antipyrine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.24e-05	0.00151	CbGpPWpGaD
Antipyrine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.11e-05	0.00149	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.06e-05	0.00149	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.06e-05	0.00149	CbGpPWpGaD
Antipyrine—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.05e-05	0.00148	CbGpPWpGaD
Antipyrine—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.92e-05	0.00146	CbGpPWpGaD
Antipyrine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.86e-05	0.00145	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	8.8e-05	0.00144	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	8.77e-05	0.00144	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	8.77e-05	0.00144	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.76e-05	0.00144	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.65e-05	0.00142	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.56e-05	0.0014	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	8.51e-05	0.0014	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.49e-05	0.00139	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.12e-05	0.00133	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	8.09e-05	0.00133	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	8.02e-05	0.00132	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.96e-05	0.0013	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.89e-05	0.00129	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	7.89e-05	0.00129	CbGpPWpGaD
Antipyrine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.82e-05	0.00128	CbGpPWpGaD
Antipyrine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.71e-05	0.00126	CbGpPWpGaD
Antipyrine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.57e-05	0.00124	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.48e-05	0.00123	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.46e-05	0.00122	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.42e-05	0.00122	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.37e-05	0.00121	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.37e-05	0.00121	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.37e-05	0.00121	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	7.28e-05	0.00119	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.08e-05	0.00116	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.08e-05	0.00116	CbGpPWpGaD
Antipyrine—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	7.03e-05	0.00115	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	7.01e-05	0.00115	CbGpPWpGaD
Antipyrine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.98e-05	0.00114	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	6.93e-05	0.00114	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	6.93e-05	0.00114	CbGpPWpGaD
Antipyrine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.89e-05	0.00113	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.87e-05	0.00113	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.74e-05	0.0011	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	6.71e-05	0.0011	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.58e-05	0.00108	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.47e-05	0.00106	CbGpPWpGaD
Antipyrine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.42e-05	0.00105	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	6.38e-05	0.00105	CbGpPWpGaD
Antipyrine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.37e-05	0.00104	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	6.34e-05	0.00104	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.34e-05	0.00104	CbGpPWpGaD
Antipyrine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.33e-05	0.00104	CbGpPWpGaD
Antipyrine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.28e-05	0.00103	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.26e-05	0.00103	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	6.25e-05	0.00102	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.02e-05	0.000987	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6e-05	0.000984	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	5.99e-05	0.000983	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	5.99e-05	0.000983	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	5.98e-05	0.00098	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	5.91e-05	0.000968	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.9e-05	0.000967	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.89e-05	0.000965	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.66e-05	0.000928	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.59e-05	0.000916	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.54e-05	0.000909	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.52e-05	0.000905	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	5.48e-05	0.000899	CbGpPWpGaD
Antipyrine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.44e-05	0.000892	CbGpPWpGaD
Antipyrine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.36e-05	0.00088	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	5.35e-05	0.000877	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	5.35e-05	0.000877	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	5.33e-05	0.000874	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	5.33e-05	0.000873	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.13e-05	0.000841	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	5.12e-05	0.000839	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.1e-05	0.000836	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.08e-05	0.000834	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	5.01e-05	0.000822	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.99e-05	0.000818	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	4.92e-05	0.000807	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	4.92e-05	0.000807	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	4.89e-05	0.000802	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.88e-05	0.0008	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.88e-05	0.0008	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	4.82e-05	0.00079	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.81e-05	0.000788	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	4.79e-05	0.000786	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	4.69e-05	0.000769	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.55e-05	0.000746	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.55e-05	0.000746	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.5e-05	0.000738	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.46e-05	0.000731	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	4.44e-05	0.000727	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	4.33e-05	0.00071	CbGpPWpGaD
Antipyrine—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	4.3e-05	0.000704	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.28e-05	0.000701	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.27e-05	0.000701	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.25e-05	0.000697	CbGpPWpGaD
Antipyrine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.2e-05	0.000688	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.18e-05	0.000686	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.17e-05	0.000683	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.17e-05	0.000683	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.15e-05	0.00068	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.14e-05	0.000679	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.04e-05	0.000662	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	4.01e-05	0.000657	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.93e-05	0.000645	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.9e-05	0.000639	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.89e-05	0.000637	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.88e-05	0.000636	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	3.87e-05	0.000634	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.85e-05	0.000632	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.81e-05	0.000625	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.8e-05	0.000623	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	3.72e-05	0.000611	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.64e-05	0.000597	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.61e-05	0.000591	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	3.58e-05	0.000587	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	3.56e-05	0.000583	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.54e-05	0.000581	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.53e-05	0.000578	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.52e-05	0.000576	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	3.51e-05	0.000575	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.39e-05	0.000556	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.33e-05	0.000546	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	3.28e-05	0.000538	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.22e-05	0.000527	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.22e-05	0.000527	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.21e-05	0.000527	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	3.08e-05	0.000505	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.06e-05	0.000501	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	3.03e-05	0.000497	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.01e-05	0.000494	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	0.000484	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.94e-05	0.000482	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.94e-05	0.000482	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.93e-05	0.000481	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.88e-05	0.000472	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.79e-05	0.000458	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.76e-05	0.000453	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.74e-05	0.000448	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.73e-05	0.000447	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.71e-05	0.000444	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.7e-05	0.000442	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.67e-05	0.000438	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.57e-05	0.000422	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.49e-05	0.000408	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	2.49e-05	0.000408	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.47e-05	0.000404	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000404	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	2.43e-05	0.000398	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.41e-05	0.000395	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.33e-05	0.000381	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.28e-05	0.000374	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.27e-05	0.000372	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.25e-05	0.000368	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	2.24e-05	0.000367	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000364	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.11e-05	0.000346	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.07e-05	0.00034	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.04e-05	0.000335	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.03e-05	0.000332	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.03e-05	0.000332	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.96e-05	0.000321	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.000315	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	1.92e-05	0.000315	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.9e-05	0.000312	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.85e-05	0.000303	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.000295	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.76e-05	0.000289	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.73e-05	0.000284	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.66e-05	0.000273	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.64e-05	0.00027	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.63e-05	0.000267	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.58e-05	0.000259	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.58e-05	0.000259	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	1.57e-05	0.000257	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.56e-05	0.000255	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.55e-05	0.000254	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000248	CbGpPWpGaD
Antipyrine—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000243	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	0.000243	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000238	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.42e-05	0.000233	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.39e-05	0.000228	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.34e-05	0.000219	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.000219	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.27e-05	0.000208	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000204	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000202	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000196	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.19e-05	0.000196	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-05	0.000192	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	0.00018	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.00018	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.09e-05	0.000178	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000177	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000176	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.01e-05	0.000166	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000166	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000165	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1e-05	0.000164	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.3e-06	0.000153	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	9.03e-06	0.000148	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.55e-06	0.00014	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	8.3e-06	0.000136	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	8.23e-06	0.000135	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.18e-06	0.000134	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.02e-06	0.000131	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.18e-06	0.000118	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	7.03e-06	0.000115	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.93e-06	0.000114	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.6e-06	0.000108	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.19e-06	0.000101	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.69e-06	9.33e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.64e-06	9.25e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.43e-06	8.9e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.82e-06	7.9e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.72e-06	6.1e-05	CbGpPWpGaD
